SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-324463
Filing Date
2021-11-09
Accepted
2021-11-09 16:12:56
Documents
14
Period of Report
2021-11-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d257796d8k.htm   iXBRL 8-K 27482
2 EX-99.1 d257796dex991.htm EX-99.1 10968
6 GRAPHIC g257796g1109061239952.jpg GRAPHIC 2968
  Complete submission text file 0001193125-21-324463.txt   165592

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20211108.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20211108_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20211108_pre.xml EX-101.PRE 10946
7 EXTRACTED XBRL INSTANCE DOCUMENT d257796d8k_htm.xml XML 3233
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 211392292
SIC: 2836 Biological Products, (No Diagnostic Substances)